What is Januvia?
Januvia is a prescription drug designed to help improve the blood sugar level of adults who suffer from type 2 diabetes mellitus. It’s part of a category of medicines that are known as DPP-4 inhibitors, which aid in regulating blood glucose levels by improving the body’s ability to decrease elevated levels of sugar.
Mechanism of Action
Sitagliptin is a drug that blocks the enzyme dipeptidyl-peptidase-4 (DPP-4), which is responsible for the breakdown of the hormones that incretin is made up of, like GLP-1, as well as GIP. The hormones boost pancreatic insulin production and reduce glucagon production, particularly following meals. This helps in reducing blood glucose levels.
By preventing the degradation of incretins by sitagliptin, it increases the levels of these substances and extends its effects, leading to more effective blood sugar management.
Indications
The Januvia 50 mg dose is used to treat:
- The treatment of Type 2 diabetes mellitus is an addition to fitness and diet.
- Utilized alone (monotherapy) or with other agents to treat diabetes, like metformin, sulfonylureas, and insulin.
Dosage and Administration
- The standard dose for Januvia can be 50 mg twice a day. It can be increased by 100 mg, based on the patient’s response and the kidney’s functioning.
- It can be consumed in combination with and without food.
- The need for dose adjustments is evident for those suffering from kidney impairment.
Pharmacokinetics
- Absorption: Fastly absorbed, with plasma levels within 1 to 4 hours.
- Half-life: Approximately 12.4 hours.
- Metabolism: Hepatic metabolism is minimal.
- Excretion: Primarily, the kidney (about 79% of the excreted remains unchanged through urine).
Side Effects
Common side effects:
- Nasopharyngitis (common cold symptoms)
- Headache
- Upper respiratory tract infections
- Gastrointestinal discomfort
Serious side effects (rare):
- Pancreatitis (inflammation of the pancreas)
- Hypoglycemia (particularly when it is used in conjunction, especially when combined with insulin or sulfonylureas)
- Reactions to allergens, such as the rash and angioedema
Contraindications
- Hypersensitivity is known to sitagliptin, or any other component of the formula.
Precautions
- Be aware of any indications for pancreatitis (severe abdominal discomfort).
- Be cautious in patients suffering from kidney impairment. A dose adjustment is needed.
- Not approved for use in type 1 diabetes or diabetic ketoacidosis.
- Monitoring the levels of blood glucose is vital.
Drug Interactions
- Increases the risk of having hypoglycemia if combined with insulin or sulfonylureas.
- There is no significant interaction between commonly used medications. However, you should be sure to inform all medications to your physician.
Patient Counseling
- Consume Januvia at a similar time each day.
- Keep up your diet and workout routine according to the guidelines.
- Contact your physician if you have symptoms that include nausea, abdominal pain, vomiting, or jaundice.
- A regular blood sugar check is crucial.
- Don’t skip dosages or cease medicine without consulting your physician.
















Reviews
There are no reviews yet.